ynergistic antifungal activity of statin – azole associations as witnessed y Saccharomyces cerevisiae-and Candida utilis-bioassays and ergosterol uantification aría

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Antifungal Activity and the Potential Correlation with Statin-Producing Ability: An Optimized Screening Applied to Filamentous Fungi from Las Yungas Subtropical Rainforest

  2010cited by this paper
• Antifungal peptides secreted by filamentous fungi as promising new agents in human therapy.

  2009cited by this paper
• Inhibition of Candida albicans by Fluvastatin Is Dependent on pH

  2009cited by this paper
• Evaluation of the antifungal potential of Brazilian Cerrado medicinal plants

  2009cited by this paper
• Cloning of the Rhizomucor miehei 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene and its heterologous expression in Mucor circinelloides

  2008cited by this paper
• Potent anti‐microbial activity of traditional Chinese medicine herbs against Candida species

  2007cited by this paper
• Biological consequences of statins in Candida species and possible implications for human health.

  2007cited by this paper
• Simvastatin reduces ergosterol levels, inhibits growth and causes loss of mtDNA in Candida glabrata.

  2007cited by this paper
• Interactions between statins and Penicillium chrysogenum antifungal protein (PAF) to inhibit the germination of sporangiospores of different sensitive Zygomycetes.

  2007cited by this paper
• Effects of the sporulation conditions on the lovastatin production by Aspergillus terreus

  2006cited by this paper
• Growth inhibition of Candida species and Aspergillus fumigatus by statins.

  2006cited by this paper
• Lovastatin Has Significant Activity against Zygomycetes and Interacts Synergistically with Voriconazole

  2006cited by this paper
• Identification of Candida fabianii as a cause of lethal septicaemia

  2006cited by this paper
• Benefit versus risk in statin treatment.

  2006cited by this paper
• Lovastatin possesses a fungistatic effect against Candida albicans, but does not trigger apoptosis in this opportunistic human pathogen.

  2006cited by this paper
• Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans.

  2003cited by this paper
• Fluconazole toxicity is independent of oxidative stress and apoptotic effector mechanisms in Saccharomyces cerevisiae

  2003cited by this paper
• Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs

  2002cited by this paper
• Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans.

  2002cited by this paper
• Prevalence of Candida spp. in hospitalized patients and their risk factors

  2002cited by this paper
• Dual physiological effects of antifungal sterol biosynthetic inhibitors on enzyme targets and on transcriptional regulation

  1999cited by this paper
• Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro.

  1999cited by this paper
• Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.

  1999cited by this paper
• Chronic Urinary Tract Infection Due toCandida utilis

  1999cited by this paper
• Emergence of Saccharomyces cerevisiae as a human pathogen: Implications for biotechnology

  1999cited by this paper
• Applications of yeast in biotechnology: protein production and genetic analysis.

  1999cited by this paper
• In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin

  1998cited by this paper
• Resistencia in vitro al fluconazol e itraconazol en aislamientos clínicos de Candida spp y Cryptococcus neo

  1997cited by this paper
• In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans

  1997cited by this paper
• Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro

  1995cited by this paper
• Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.

  1995cited by this paper
• Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

  1993cited by this paper
• Resolutive Candida utilis fungemia in a nonneutropenic patient

  1993cited by this paper
• Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy.

  1993cited by this paper
• Molecular genetic analysis of azole antifungal mode of action.

  1993cited by this paper
• Invasive infection with Saccharomyces cerevisiae: report of three cases and review.

  1990cited by this paper
• Combination therapy in systemic mycosis.

  1990cited by this paper
• Effects of lovastatin (mevinolin) on sterol levels and on activity of azoles in Saccharomyces cerevisiae

  1990cited by this paper
• Isolation and characterization of mevinolin resistant mutants of Saccharomyces cerevisiae.

  1988cited by this paper
• Catheter-associated Candida utilis fungemia in a patient with acquired immunodeficiency syndrome: species verification with a molecular probe

  1988cited by this paper
• Annotations to the Pathogenicity and Toxicity of Yeasts as used in Production of Single Cell Proteins: Bemerkungen zur Pathogenität und Toxizität von Hefen in der Herstellung von Einzellerprotein *

  1981cited by this paper

• ANTIFUNGAL AND SYNERGISTIC EFFECTS OF ZNO NANOPARTICLES AGAINST T.VERRUCOSUM CAUSED RINGWORM IN COWS

  2023cites this paper
• Therapeutic Drug Monitoring in Fungal Infections: the Dawn of Proactive Monitoring

  2021cites this paper
• Caracterización de Candida spp. aisladas a partir de urocultivos en la ciudad de Medellín

  2020cites this paper
• AIDS Related Histoplasmosis, Treatment and Prophylaxis: the Mycology Unit of FJ Muniz Hospital Experience

  2020cites this paper
• Antimicrobial activity of various ethanolic plant extracts against pathogenic multi drug resistant Candida spp.

  2017cites this paper
• Liposomal amphotericin B induced pancytopenia-a rare case report

  2017cites this paper
• SAP(1-3) Gene Expression in High Proteinase Producer Candida Species Strains Isolated from Iranian Patients with Different Candidosis

  2016cites this paper
• Can submerged macrophytes be effective for controlling waterborne phytopathogens in irrigation ponds? An experimental approach using microcosms

  2014cites this paper
• PROBIOTIC POTENTIAL OF YEASTS ISOLATED FROM TRADITIONAL INDIAN FERMENTED FOODS

  2013cites this paper